Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription Articles published in Curr Opin Nephrol Hypertens Retrieve available abstracts of 29 articles: HTML format

Single Articles

April 2024
1. DISSANAYAKE LV, Palygin O, Staruschenko A
   Lysine and salt-sensitive hypertension.
   Curr Opin Nephrol Hypertens. 2024 Apr 22. doi: 10.1097/MNH.0000000000000994.
   PubMed     Abstract available
   
   
   March 2024
2. AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
   The TMEM16A channel as a potential therapeutic target in vascular disease.
   Curr Opin Nephrol Hypertens. 2024;33:161-169.
   PubMed     Abstract available
   
   
   January 2024
3. DEMIRCI M, Hinton A, Kirabo A
   Dendritic cell epithelial sodium channel induced inflammation and salt-sensitive hypertension.
   Curr Opin Nephrol Hypertens. 2024 Jan 8. doi: 10.1097/MNH.0000000000000963.
   PubMed     Abstract available
   
   
   
4. BENSON LN, Mu S
   Interferon gamma in the pathogenesis of hypertension - recent insights.
   Curr Opin Nephrol Hypertens. 2024 Jan 5. doi: 10.1097/MNH.0000000000000966.
   PubMed     Abstract available
   
   
   
5. ALVAREZ-ELIAS AC, Brenner BM, Luyckx VA
   Climate change and its influence in nephron mass.
   Curr Opin Nephrol Hypertens. 2024;33:102-109.
   PubMed     Abstract available
   
   
   November 2023
6. TANTISATTAMO E, Ferrey AJ, Reddy UG, Malik FT, et al
   A paradigm shift from office to home-based blood pressure measurement approaches in kidney transplant recipients.
   Curr Opin Nephrol Hypertens. 2023 Nov 9. doi: 10.1097/MNH.0000000000000951.
   PubMed     Abstract available
   
   
   
7. LUCAS B, Taal MW
   Blood pressure targets in chronic kidney disease: still no consensus.
   Curr Opin Nephrol Hypertens. 2023;32:497-501.
   PubMed     Abstract available
   
   
   September 2023
8. CAMAFORT M, Ihm SH, Ruilope LM
   Renal denervation for the treatment of hypertension and kidney disease.
   Curr Opin Nephrol Hypertens. 2023 Sep 14. doi: 10.1097/MNH.0000000000000928.
   PubMed     Abstract available
   
   
   
9. MAGANA-AVILA GR, Castaneda-Bueno M
   Role of NCC in the pathophysiology of hypertension in primary aldosteronism.
   Curr Opin Nephrol Hypertens. 2023;32:476-481.
   PubMed     Abstract available
   
   
   
10. CHAVEZ-CANALES M, Garcia JA, Gamba G
    Regulation of the WNK4-SPAK-NCC pathway by the calcium-sensing receptor.
    Curr Opin Nephrol Hypertens. 2023;32:451-457.
    PubMed     Abstract available
    
    
    
11. DRAWZ P, Baumann D, Dayton A
    Renal denervation: recent developments in clinical and preclinical research.
    Curr Opin Nephrol Hypertens. 2023;32:404-411.
    PubMed     Abstract available
    
    
    June 2023
12. KOTTA PA, Nambi V
    Biomarker guided management of hypertension.
    Curr Opin Nephrol Hypertens. 2023 Jun 12. doi: 10.1097/MNH.0000000000000905.
    PubMed     Abstract available
    
    
    May 2023
13. ABBASI M, Teakell J
    Literature review: are NSAIDs harmful and is acetaminophen well tolerated?
    Curr Opin Nephrol Hypertens. 2023;32:284-289.
    PubMed     Abstract available
    
    
    April 2023
14. CORNELIUS RJ, Maeoka Y, McCormick JA
    Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension.
    Curr Opin Nephrol Hypertens. 2023 Apr 13. doi: 10.1097/MNH.0000000000000891.
    PubMed     Abstract available
    
    
    March 2023
15. HEBERT JF, Funahashi Y, Hutchens MP
    Harm! foul! How acute kidney injury SHReDDs patient futures.
    Curr Opin Nephrol Hypertens. 2023;32:165-171.
    PubMed     Abstract available
    
    
    
16. GUPTA S, Petras L, Tufail MU, Rodriguez Salazar JD, et al
    Hypertension in Pregnancy: What We Now Know.
    Curr Opin Nephrol Hypertens. 2023;32:153-164.
    PubMed     Abstract available
    
    
    
17. AVVISATO R, Jankauskas SS, Varzideh F, Kansakar U, et al
    Sortilin and hypertension.
    Curr Opin Nephrol Hypertens. 2023;32:134-140.
    PubMed     Abstract available
    
    
    
18. VATISH M, Powys VR, Cerdeira AS
    Novel therapeutic and diagnostic approaches for preeclampsia.
    Curr Opin Nephrol Hypertens. 2023;32:124-133.
    PubMed     Abstract available
    
    
    
19. MELLOTT E, Faulkner JL
    Mechanisms of leptin-induced endothelial dysfunction.
    Curr Opin Nephrol Hypertens. 2023;32:118-123.
    PubMed     Abstract available
    
    
    December 2022
20. DEUSSEN A, Kopaliani I
    Targeting inflammation in hypertension.
    Curr Opin Nephrol Hypertens. 2022 Dec 8. doi: 10.1097/MNH.0000000000000862.
    PubMed     Abstract available
    
    
    September 2022
21. EHRET E, Hummler E
    Lessons learned about epithelial sodium channels from transgenic mouse models.
    Curr Opin Nephrol Hypertens. 2022;31:493-501.
    PubMed     Abstract available
    
    
    
22. ALI S, Navaneethan SD, Virani SS, Gregg LP, et al
    Revisiting diuretic choice in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:406-413.
    PubMed     Abstract available
    
    
    July 2022
23. GEORGIANOS PI, Agarwal R
    Management of hypertension in advanced kidney disease.
    Curr Opin Nephrol Hypertens. 2022;31:374-379.
    PubMed     Abstract available
    
    
    March 2022
24. ABU SALMAN L, Cohen JB
    Updates in hypertension: new trials, targets and ways of measuring blood pressure.
    Curr Opin Nephrol Hypertens. 2022 Mar 4. pii: 00041552-900000000-98929.
    PubMed     Abstract available
    
    
    
25. DIKALOV S, Dikalova A
    Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension.
    Curr Opin Nephrol Hypertens. 2022;31:151-156.
    PubMed     Abstract available
    
    
    November 2021
26. HANNA RM, Ahdoot RS, Kim MS, Jhaveri KD, et al
    Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98951.
    PubMed     Abstract available
    
    
    
27. TANTISATTAMO E, Hamiduzzaman A, Sohn P, Ahdoot R, et al
    Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98955.
    PubMed     Abstract available
    
    
    May 2021
28. HUNDEMER GL, Kline GA, Leung AA
    How common is primary aldosteronism?
    Curr Opin Nephrol Hypertens. 2021;30:353-360.
    PubMed     Abstract available
    
    
    January 2021
29. KOURI AM, Rheault MN
    Cardiovascular disease in children with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99002.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.